T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Ewer KJ., Barrett JR., Belij-Rammerstorfer S., Sharpe H., Makinson R., Morter R., Flaxman A., Wright D., Bellamy D., Bittaye M., Dold C., Provine NM., Aboagye J., Fowler J., Silk SE., Alderson J., Aley PK., Angus B., Berrie E., Bibi S., Cicconi P., Clutterbuck EA., Chelysheva I., Folegatti PM., Fuskova M., Green CM., Jenkin D., Kerridge S., Lawrie A., Minassian AM., Moore M., Mujadidi Y., Plested E., Poulton I., Ramasamy MN., Robinson H., Song R., Snape MD., Tarrant R., Voysey M., Watson MEE., Douglas AD., Hill AVS., Gilbert SC., Pollard AJ., Lambe T.

DOI

10.1038/s41591-020-01194-5

Type

Journal article

Journal

Nature Medicine

Publisher

Springer Science and Business Media LLC

Publication Date

17/12/2020

Permalink Original publication